[헬스코리아뉴스 / 이상훈] It is noteworthy whether stocks related to ivermectin, an anthelmintic drug that once attracted a lot of attention, will find an opportunity for a rebound as they have recently been unable to do so. First off today is a good start. As of 9:30 a.m., ivermectin-related stocks mostly started on an uptrend. These include Samsung Pharmaceutical, Shinpoong Pharmaceutical, and Myungmoon Pharmaceutical.
Ivermectin started to attract public attention because of foreign media released last month. According to the foreign press, an Australian research team conducted an ivermectin cell culture experiment on 1,400 people, and the corona 19 virus genetic material was killed within 48 hours. Since then, related studies have been conducted around the world.
Ivermectin is an anthelmintic repellent that treats various parasitic infections such as head lice, scabies, strong blindness, chondrosis, flatworm, roundworm, and lymphadenopathy. The expectation that ivermectin, which has high accessibility and low cost, will play a role as a game changer is growing in a situation where there is no clear cure for Corona 19 yet.
Until now, malaria treatment hydroxychloroquine, HIV treatment’lopinavir + ritonavir’, and antihypertensive drug losartan have emerged as treatments for Corona 19, but there is no clear treatment yet.
Representative ivermectin-related stocks include Samsung Pharmaceutical, Shinpoong Pharmaceutical, and Myungmoon Pharmaceutical. First, Samsung Pharmaceutical recorded the upper limit on January 6, when the foreign press was announced, and recorded a closing price of 1,750 won.
Myung Problem Drug closes at 8,650 won on January 6, when the clinical trial results were announced, but then gradually declined and ended at 6090 won on the 18th. It has declined for the last three consecutive trading days.
Shinpoong Pharm, which once closed at close to 200,000 won, also fell 3.58% on the 18th, recording 75,500 won on the 18th, as the last three consecutive trading days fell.
It is noteworthy whether ivermectin-related stocks can break the stagnation and rebound.
Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited